https://freeline.life/wp-content/uploads/Freeline_Logo_Red-300x66.png00jeremiah@devisedesigns.comhttps://freeline.life/wp-content/uploads/Freeline_Logo_Red-300x66.pngjeremiah@devisedesigns.com2023-04-04 06:00:562023-04-04 06:00:56Freeline Reports Full Year 2022 Financial Results and Provides Corporate Update
https://freeline.life/wp-content/uploads/Freeline_Logo_Red-300x66.png00jeremiah@devisedesigns.comhttps://freeline.life/wp-content/uploads/Freeline_Logo_Red-300x66.pngjeremiah@devisedesigns.com2023-02-10 06:00:532023-02-10 06:00:53Freeline Announces Closing of Sale of Its CMC-Focused German Subsidiary
https://freeline.life/wp-content/uploads/Freeline_Logo_Red-300x66.png00jeremiah@devisedesigns.comhttps://freeline.life/wp-content/uploads/Freeline_Logo_Red-300x66.pngjeremiah@devisedesigns.com2023-01-19 07:02:012023-01-19 07:02:01Freeline Publishes Preclinical Proof-of-Concept Data for FLT190, its AAV Gene Therapy Candidate for Fabry Disease, in the Nature Journal Gene Therapy
https://freeline.life/wp-content/uploads/Freeline_Logo_Red-300x66.png00jeremiah@devisedesigns.comhttps://freeline.life/wp-content/uploads/Freeline_Logo_Red-300x66.pngjeremiah@devisedesigns.com2022-11-29 15:01:552022-11-29 15:01:55Freeline Receives Approval to Transfer to Nasdaq Capital Market
https://freeline.life/wp-content/uploads/Freeline_Logo_Red-300x66.png00jeremiah@devisedesigns.comhttps://freeline.life/wp-content/uploads/Freeline_Logo_Red-300x66.pngjeremiah@devisedesigns.com2022-11-09 06:00:432022-11-09 06:00:43Freeline to Present at the Stifel Healthcare Conference
https://freeline.life/wp-content/uploads/Freeline_Logo_Red-300x66.png00jeremiah@devisedesigns.comhttps://freeline.life/wp-content/uploads/Freeline_Logo_Red-300x66.pngjeremiah@devisedesigns.com2022-10-04 06:00:272022-10-04 06:00:27Freeline Initiates Dosing of Second Cohort in MARVEL-1 Trial of FLT190 Gene Therapy Candidate for People with Fabry Disease